189 related articles for article (PubMed ID: 33780098)
1. Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States.
Michael Soucie J; Miller CH; Byams VR; Payne AB; Abe K; Sidonio RF; Kouides PA
Haemophilia; 2021 May; 27(3):445-453. PubMed ID: 33780098
[TBL] [Abstract][Full Text] [Related]
2. Quality of periprocedural care in patients with von Willebrand disease.
Seaman CD; Bertolet M; Zhang J; Ragni MV
Haemophilia; 2021 Sep; 27(5):830-836. PubMed ID: 34343372
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand Disease: Gaining a global perspective.
O'Sullivan JM; Tootoonchian E; Ziemele B; Makris M; Federici AB; Khayat Djambas C; El Ekiaby M; Rotellini D; Sidonio RF; Iorio A; Coffin D; Pierce GF; Stonebraker J; James PD; Lavin M
Haemophilia; 2023 Jul; 29(4):1104-1112. PubMed ID: 37216656
[TBL] [Abstract][Full Text] [Related]
4. Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres.
Soucie JM; Miller CH; Dupervil B; Le B; Buckner TW
Haemophilia; 2020 May; 26(3):487-493. PubMed ID: 32329553
[TBL] [Abstract][Full Text] [Related]
5. Reported prevalence of von Willebrand disease worldwide in relation to income classification.
Stonebraker JS; Iorio A; Lavin M; Rezende SM; Srivastava A; Pierce GF; Coffin D; Tootoonchian E; Makris M
Haemophilia; 2023 Jul; 29(4):975-986. PubMed ID: 37276350
[TBL] [Abstract][Full Text] [Related]
6. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States.
Kirtava A; Crudder S; Dilley A; Lally C; Evatt B
Haemophilia; 2004 Mar; 10(2):158-61. PubMed ID: 14962204
[TBL] [Abstract][Full Text] [Related]
7. Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres.
Franchini M; Di Perna C; Santoro C; Castaman G; Siboni SM; Zanon E; Linari S; Gresele P; Pasca S; Coppola A; Santoro R; Napolitano M; Ranalli P; Tagliaferri A;
Semin Thromb Hemost; 2016 Feb; 42(1):36-41. PubMed ID: 26595151
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc Analysis.
van Galen KPM; Timmer M; de Kleijn P; Leebeek FWG; Foppen W; Schutgens REG; Eikenboom J; Meijer K; Fijnvandraat K; Laros-van Gorkom BAP; Twisk JW; Mauser-Bunschoten EP; Fischer K;
Thromb Haemost; 2018 Oct; 118(10):1690-1700. PubMed ID: 30273954
[TBL] [Abstract][Full Text] [Related]
9. Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.
Miller CH; Soucie JM; Byams VR; Payne AB; Sidonio RF; Buckner TW; Bean CJ
Haemophilia; 2021 Nov; 27(6):1037-1044. PubMed ID: 34480812
[TBL] [Abstract][Full Text] [Related]
10. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.
Kirtava A; Drews C; Lally C; Dilley A; Evatt B
Haemophilia; 2003 May; 9(3):292-7. PubMed ID: 12694520
[TBL] [Abstract][Full Text] [Related]
11. Incidence of von Willebrand disease in Denmark, 1995-2016: A cohort study.
Laursen ASD; Rasmussen TB; Chiu GR; Brouwer ES; Poulsen LH; Mikkelsen EM
Haemophilia; 2021 Mar; 27(2):277-282. PubMed ID: 33550641
[TBL] [Abstract][Full Text] [Related]
12. [Type 2N von Willebrand disease (Normandy)].
Morales-De la Vega A; Reyes-Maldonado E; Martínez-Murillo C; Quintana-González S
Rev Med Inst Mex Seguro Soc; 2008; 46(1):55-62. PubMed ID: 18647572
[TBL] [Abstract][Full Text] [Related]
13. Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register.
Seaman CD; Yabes J; Comer DM; Ragni MV
J Thromb Haemost; 2015 Nov; 13(11):1999-2003. PubMed ID: 26368360
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of slightly reduced von Willebrand factor activity.
Bykowska K; Ceglarek B
Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand disease in the United States: a perspective from Wisconsin.
Flood VH; Gill JC; Friedman KD; Bellissimo DB; Haberichter SL; Montgomery RR
Semin Thromb Hemost; 2011 Jul; 37(5):528-34. PubMed ID: 22102196
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of Haemate® P in von Willebrand disease: a 25-year retrospective observational study.
Miesbach W; Krekeler S; Wolf Z; Seifried E
Thromb Res; 2015 Mar; 135(3):479-84. PubMed ID: 25595881
[TBL] [Abstract][Full Text] [Related]
18. Translating the success of prophylaxis in haemophilia to von Willebrand disease.
Miesbach W; Berntorp E
Thromb Res; 2021 Mar; 199():67-74. PubMed ID: 33445035
[TBL] [Abstract][Full Text] [Related]
19. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
Makris M; Federici AB; Mannucci PM; Bolton-Maggs PHB; Yee TT; Abshire T; Berntorp E
Haemophilia; 2015 May; 21(3):338-342. PubMed ID: 25381842
[TBL] [Abstract][Full Text] [Related]
20. Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort.
Alesci RS; Krekeler S; Seifried E; Miesbach W
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):320-3. PubMed ID: 22473050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
